1. Home
  2. FURY vs BNR Comparison

FURY vs BNR Comparison

Compare FURY & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fury Gold Mines Limited

FURY

Fury Gold Mines Limited

HOLD

Current Price

$0.57

Market Cap

115.8M

ML Signal

HOLD

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

HOLD

Current Price

$11.60

Market Cap

126.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FURY
BNR
Founded
2008
2014
Country
Canada
China
Employees
N/A
N/A
Industry
Precious Metals
Medical Specialities
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
115.8M
126.5M
IPO Year
2011
2019

Fundamental Metrics

Financial Performance
Metric
FURY
BNR
Price
$0.57
$11.60
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$1.70
N/A
AVG Volume (30 Days)
320.9K
36.6K
Earning Date
08-11-2026
06-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$111.65
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.50
$6.79
52 Week High
$1.02
$41.72

Technical Indicators

Market Signals
Indicator
FURY
BNR
Relative Strength Index (RSI) 41.70 N/A
Support Level $0.51 N/A
Resistance Level $0.57 N/A
Average True Range (ATR) 0.03 0.00
MACD -0.01 0.00
Stochastic Oscillator 1.98 0.00

Price Performance

Historical Comparison
FURY
BNR

About FURY Fury Gold Mines Limited

Fury Gold Mines Ltd is a Canadian-focused high-grade gold exploration company. The company's projects are strategically positioned in two prolific mining regions: the Eeyou Istchee James Bay Region of Quebec and the Kitikmeot Region in Nunavut. Fury Gold's project portfolio comprises the Committee Bay gold project in Nunavut, and the Eau Claire gold, Sakami gold, Elmer East gold and lithium, and Eleonore South gold projects in Quebec. Additionally, it also owns interests in the Kipawa rare earths project and has full ownership of the Zeus heavy rare earths project, both located in the Temiscamingue region of Quebec. The company operates in two reportable segments: Quebec and Nunavut.

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.

Share on Social Networks: